Medicines, once seen primarily as a matter of public health, are emerging as crucial assets in a more contested world. The change has been gradual, but recent crises have made it impossible to ignore.
Governed “glass box” AI with line-by-line traceability, audit logs, and judge agents is positioned as essential for high-stakes R&D and regulator-inspectable decisions. Embedding compliance into ...
Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are proposing bans. By Paula Span Tamar Abrams had a lousy couple of years in 2022 ...
Pharmacy technicians assist and support licensed pharmacists in providing services to customers, including prescription medications, over-the-counter drugs, medical equipment and supplies, ...
Objectives The study aims to present recommendations for a revised Doctor of Pharmacy (Pharm. D) curriculum that aligns with regional needs and international standards of pharmacy education. Design An ...
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...
LOWERING DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced nine new agreements with major pharmaceutical companies to lower prescription drug prices for Americans in line ...
ToniFlin is an Android-based application for adjusting ingredient levels in parenteral formulations to achieve isotonicity. Built on the cryoscopic method, it enables flexible, accurate, and rapid ...
Steve Forbes explains how Puerto Rico can once again become a pharmaceutical powerhouse and help to reshore U.S. drug manufacturing. For decades Puerto Rico was one of the world’s premier ...
Artificial intelligence continues to advance at an astonishing pace. We have tools that can process millions of tokens at once, scan vast repositories of information and generate responses that sound ...
President Donald Trump signed a memorandum that aims to crack down on direct-to-consumer prescription drug ads, in a move that stops short of an outright ban. The Trump administration will send out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results